Loading...

Columbia Care Inc.

CCHW.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.56
CA$0.01(1.82%)

Columbia Care Inc. (CCHW.CN) Stock Overview

Explore Columbia Care Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.6/100

Key Financials

Market Cap228.7M
P/E Ratio-0.38
EPS (TTM)$-1.37
ROE-1.08%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.35

CCHW.CN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Columbia Care Inc. (CCHW.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.38 and a market capitalization of 228.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for CCHW.CNStats details for CCHW.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CCHW.CNAnalyst Recommendations details for CCHW.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.

CEO

Nicholas Keane Vita

Employees

2,505

Headquarters

680 Fifth Avenue, New York City, NY

Founded

2020

Frequently Asked Questions

;